Brief: Chemometec Q3 EBITDA Rises To DKK 58.6 Mln

ChemoMetec A/S

05/05/2022 07:44

May 5 (Reuters) - Chemometec A/S  CHEMM.CO :
    * CONTINUED GROWTH IN Q3 2021/22 AND ACHIEVED NET SALES OF
DKK
111.9M, AN INCREASE OF 60% COMPARED TO THE SAME QUARTER OF THE
PREVIOUS YEAR.
    * THE RESULT FROM PRIMARY OPERATIONS, EBITDA, INCREASED IN
Q3 TO
DKK 58.6 MILLION FROM DKK 31.6M IN THE SAME PERIOD LAST YEAR, AN
INCREASE OF 86%
    * THE GROWTH IN SALES IS MAINLY ATTRIBUTABLE TO AN 82%
INCREASE IN
THE NORTH AMERICAN MARKET, WHICH ACCOUNTED FOR 56% OF
CHEMOMETEC'S TOTAL SALES
    * REPORT FOR 3RD QUARTER 2021/22 (1 JANUARY - 31 MARCH 2022)
    * NET SALES IN FISCAL 2021/22 IS EXPECTED TO BE IN THE RANGE
OF
DKK 420-425 MILLION, WHILE OPERATING PROFIT (EBITDA) IS EXPECTED
TO BE IN THE RANGE OF DKK 218-221 MILLION.

Source text for Eikon:  ID:nGNE8tQNfj 
Further company coverage:  CHEMM.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))